Effects of PrTMS on Performance
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Sleep Quality, Cognition Improvement
In brief
The purpose of this study is to assess the ability of a form of non-invasive brain stimulation called personalized repetitive transcranial magnetic stimulation, or PrTMS, to enhance cognitive performance and sleep quality from baseline metrics.
Key facts
- Study ID
- NCT05353244
- Run by
- West Virginia University
- People needed
- 0
- Starts
- 2023-12-04
- Expected to finish
- 2023-12-04
- Last updated by the study team
- 2024-01-17
Who can join
Age: 18 and older, up to 42. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female between 18-42 years of age.
You may not qualify if…
- • Unable/unwilling to commit to participating in 1x per day treatments for 6 consecutive weeks
- Outside of the age range of 18-42
- Currently undergoing hormone therapy
- History of blood clotting disorder
- History of open skull traumatic brain injury
- History of clinically significant seizure disorder
- History of clinically significant manic episodes
- Diagnosed with Diabetes Mellitus
- Individuals with a clinically defined neurological disorder including, but not limited to:
- Any condition likely to be associated with increased intracranial pressure
- Space occupying brain lesion
- History of cerebrovascular accident
- Cerebral aneurysm
- Has participated in any type of rTMS treatment within 3 months prior to the screening visit
- Currently receiving antipsychotic or anticonvulsant medication treatment
- Intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, stents, or electrodes) or any other metal object within or near the head, excluding the mouth, which cannot be safely removed
- Clinically significant medical illness, including any uncontrolled thyroid disorders, hepatic, cardiac, pulmonary and renal malfunctioning
- History of psychosis
- History of migraines
- Current thoughts of suicidal ideation or self-harm
- Substance use disorder within the past six months
- Those pregnant or actively trying to become pregnant
- Intake of one or a combination of the following drugs forms a 'Strong Potential Hazard' for application of rTMS due to their significant seizure threshold lowering potential:
- Imipramine
- Amitriptyline
Where it is running
- WVU Rockefeller Neuroscience Institute — Morgantown, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.